Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.64 | 0.02 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |